MedTrace Logo

Transit Bipartition After Sleeve Gastrectomy

NCT04782648 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-03-04

No results posted yet for this study

Summary

Retrospective analysis of 100 morbidly obese patients who underwent a transit bipartition (TB) procedure ("Single Anastomosis Sleeve Ileal bypass") for inadequate weight loss or weight recidivism after a previous sleeve gastrectomy. Data were collected prospectively in strictly pseudonymous form. The primary endpoint of the study is weight loss at 1, 3, 6 and 12 months after TB. A subgroup analysis evaluates the effect of the length of the common channel. Secondary endpoints include impact on obesity related comorbidities (type 2 diabetes, hypertension, sleep apnea, gastroesophageal reflux) as well as safety.

Conditions

  • Obesity, Morbid
  • Weight Gain
  • Bariatric Surgery Candidate

Interventions

PROCEDURE

transit bipartition

transit bipartition as revisional bariatric surgery for weight regain after sleeve gastrectomy

Sponsors & Collaborators

  • Ruhr University of Bochum

    lead OTHER

Principal Investigators

  • Markus Reiser, M.D. · Dept. Gastroenterology, Klinikum-Vest GmbH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2019-11-30
Completion
2020-12-20

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04782648 on ClinicalTrials.gov